Dr. Reddy's Makes Headway With Internally Developed Phase III Diabetes Compound
This article was originally published in The Pink Sheet Daily
Executive Summary
Type 2 diabetes compound balaglitozone could be the first innovative Indian product to reach the market.
You may also be interested in...
India First Strategy Could Speed Up Data For FDA-EU Approvals - Mumbai Conference
MUMBAI - Pharmaceutical companies may be able to take advantage of the relative speed to market in India to commercialize products earlier and obtain postmarketing data that could bolster drug approval applications filed later in the U.S. and Europe, according to Biocon Founder and Chairman Kiran Mazumdar-Shaw
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.